4-o-methyl-12-o-tetradecanoylphorbol 13-acetate has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Feng, Z; Li, D; Li, J; Luo, L; Shi, Q; Xia, J; You, Z; Zhao, L; Zuo, G | 1 |
| Moens, W; Rolin-Limbosch, S; Szpirer, C | 1 |
2 other study(ies) available for 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Liver Neoplasms
| Article | Year |
|---|---|
Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors.
Topics: Cell Movement; Down-Regulation; Ginsenosides; Hep G2 Cells; Histone Deacetylases; Humans; Liver Neoplasms; Matrix Metalloproteinase 3; Repressor Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2014 |
Effects of tumour promoters on metabolic cooperation between human hepatoma cells.
Topics: Carcinogens; Carcinoma, Hepatocellular; Cell Communication; Cell Line; Humans; Hypoxanthine Phosphoribosyltransferase; Liver Neoplasms; Phenobarbital; Tetradecanoylphorbol Acetate | 1986 |